The effect of high-dose vitamin C on renal functions in COVID–19 patients


Abstract views: 201 / PDF downloads: 71

Authors

  • Asu ÖZGÜLTEKİN University of Health Science Haydarpasa Numune Research and Training Hospital Department of Anesthesiology and Intensive Care, İstanbul, Turkey https://orcid.org/0000-0003-4307-9604
  • Abdulhalim KARAYEL University of Health Science Haydarpasa Numune Research and Training Hospital Department of Anesthesiology and Intensive Care, İstanbul, Turkey https://orcid.org/0000-0002-9835-9817
  • Seher YANATMA University of Health Science Haydarpasa Numune Research and Training Hospital Department of Anesthesiology and Intensive Care, İstanbul, Turkey https://orcid.org/0000-0003-3435-1792
  • Osman EKİNCİ University of Health Science Haydarpasa Numune Research and Training Hospital Department of Anesthesiology and Intensive Care, İstanbul, Turkey https://orcid.org/0000-0002-7891-1774

DOI:

https://doi.org/10.51271/KMJ-0059

Keywords:

Covid-19, Vitamin C, renal dysfunction, oxalate nephropaty

Abstract

 

Background: With its important properties, Vitamin C has been used in several diseases and sepsis. COVID-19 may cause sepsis, and therefore high dose Vitamin C has been integrated to the treatment protocols.Concerning the potential risk of oxalate nephropaty related with the use of long term or high dose Vitamin C, we retrospectively evaluated the COVID-19 patients treated with the high dose intravenous Vitamin C, in terms of kidney dysfunction.

Material and Method: Critically ill COVID-19 patients who were given Vitamin C 45-50 gr/day/5 days (Group C, n=21), and the ones who did not (Group NC, n=22) along with the hydroxychloroquine- favipiravir treatment were compared in terms of developing renal dysfunction within the 15 days of ICU stay.

Results: There were no difference in the development of renal dysfunction between the groups with and without Vitamin C treatment (p>0.05). But when the patients who had KDIGO stage 1 kidney damage on admission, and had worsening renal dysfunction during ICU stay were excluded, patients groups were more similar and the development of the renal failure was significantly more in Vitamin C group(p<0.05).

Conclusion: We conclude that when administering high dose parenteral Vitamin C, kidney functions should be carefully assessed.

References

Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study. Chest 2017; 151: 1229-38.

Zabet MH, Mohammadi M, Ramezani M, et al. Effect of high-dose ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm Pract 2016; 5: 94-100.

Kashiouris MG, L’Heureux M, Cable CA, et al. The emerging role of vitamin C as a treatment for sepsis .Nutrients 2020; 12: 292.

Fukushima R, Yamazaki E. Vitamin C requirement in surgical patients. Curr Opin Clin Nutr Metab Care 2010; 13: 669-76.

Long CL, Maull KI, Krishnan RS, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003; 109: 144-8.

Kim WY, Jo EJ, Eom JS, et al. Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: propensity score-based analysis of a before-after cohort study. J Crit Care 2018; 47: 211-8.

Fowler AA, Truwit JD, Hite RD, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI randomized clinical trial. JAMA 2019; 322: 1261-70.

Fujii T, Luethi N, Young PJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA 2020; 323: 423-31.

Balakrishnan M, Gandhi H, Shah K, et al. Hydrocortisone, vitamin C and thiamine for the treatment of sepsis and septic shock following cardiac surgery. Indian J Anaesth 2018; 62: 934-9.

Hwang SY, Park JE, Jo IJ, et al. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial. Trials 2019; 20(1): 420.

Hager DN, Hooper MH, Bernard GR, et al. The vitamin C, thiamine and steroids in sepsis (VICTAS) protocol: a prospective, multi-center, doubleblind, adaptive sample size, randomized, placebo-controlled, clinical trial. Trials 2019; 20: 197.

Ping C, Yuping L, Jianbin G, et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock: A

randomized controlled trial. Chest 2020; 158: 174-82.

McHugh GJ, Graber ML, Freebairn RC. Fatal vitamin C-associated acute renal failure. Anaesth Intensive Care 2008; 36: 585-8.

McAllister CJ, Scowden EB, Dewberry FL, et al. Renal failure secondary to massive infusion of vitamin C. JAMA 1984; 252: 1684.

Mashour S, Turner JF, Merrell R. Acute renal failure, oxalosis, and vitamin C supplementation: A case report and review of the literature. Chest 2000; 118: 561-3.

Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: Improving global outcomes (KDIGO)-Clinical practice guideline for acute kidney injury. Kidney Int 2012; 2: 1-138.

Cheng R. Z. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? Med Drug Discov 2020; 5: 100028. Published online 2020 Mar 26.

De Melo AF, Homem-de-Mello M. High-dose intravenous vtamin C may help in cytokine storm in severe SARS-CoV-2 infection. Crit Care 2020; 24: 500.

Erol A. “High-dose intravenous vitamin C treatment for COVID-19.” OSF Preprints 2020 February 26.

Feyaerts AF, Luyten W. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition Volumes 2020; 79-80: 110948.

Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol 2020; 92: 479-90.

Boretti A, Banik BK. Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome, Pharma Nutrition 2020; 12: 100190.

Poljsak B, Ionescu JG. Pro-oxidant vs. antioxidant effects of vitamin C, Ch IV, handbook of vitamin C research: Daily, requirements... Editors: Kucharski H., Zajac J; Nova Science Publishers, Inc. 2020.

Koçyiğit A. Is the use of high-dose intravenous vitamin C safe in the treatment of SARSCOV-2? Bezmialem Science 2020; DOI: 10.14235/bas. galenos 2020; 4542.

Fowler AA, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 2014; 12: 32.

Honore PM, Jacobs R, Hendrickx I, et al. Adjuvant vitamin C treatment in sepsis-how many oranges a day keep (vasopressor-dependent) septic shock away? J Thorac Dis 2016; 8: E993-95.

Fontana F, Cazzato S, Giovanella S, et al. Oxalate nephropathy caused by excessive vitamin C administration in 2 patients with COVID-19. Kidney Int Rep 2020; 5: 1815-22.

Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Northwell Nephrology COVID-19 Research Consortium, Kidney Int 2020; 98: 209.

Downloads

Published

2022-09-22

How to Cite

ÖZGÜLTEKİN, A., KARAYEL, A., YANATMA, S., & EKİNCİ, O. (2022). The effect of high-dose vitamin C on renal functions in COVID–19 patients. Kastamonu Medical Journal, 2(3), 68–72. https://doi.org/10.51271/KMJ-0059